[HTML][HTML] Clinical inference of serum and bone sclerostin levels in patients with end-stage kidney disease
Mounting evidence indicates that sclerostin, a well-known inhibitor of bone formation, may
qualify as a clinically relevant biomarker of chronic kidney disease-related mineral and bone …
qualify as a clinically relevant biomarker of chronic kidney disease-related mineral and bone …
慢性肾脏病骨质疏松发病机制的研究进展
左彦波， 贾娟， 王红杰 - 医学研究与教育, 2019 - yxyjyjy.hbu.edu.cn
骨质疏松(osteoporosis, OP) 是慢性肾脏病(chronic kidney disease, CKD)
患者骨代谢紊乱常见的并发症之一, 是导致CKD 患者脆性骨折最主要的骨代谢性疾病 …
患者骨代谢紊乱常见的并发症之一, 是导致CKD 患者脆性骨折最主要的骨代谢性疾病 …